IL84309A - Esters of hexahydro-8-hydroxy-2,6-methano-2h-quino-lizin-3(4h)-one and related compounds,processes for their preparation and pharmaceutical compositions containing them - Google Patents
Esters of hexahydro-8-hydroxy-2,6-methano-2h-quino-lizin-3(4h)-one and related compounds,processes for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL84309A IL84309A IL84309A IL8430987A IL84309A IL 84309 A IL84309 A IL 84309A IL 84309 A IL84309 A IL 84309A IL 8430987 A IL8430987 A IL 8430987A IL 84309 A IL84309 A IL 84309A
- Authority
- IL
- Israel
- Prior art keywords
- lizin
- quino
- methano
- hexahydro
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92661986A | 1986-11-03 | 1986-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL84309A true IL84309A (en) | 1991-09-16 |
Family
ID=25453460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL84309A IL84309A (en) | 1986-11-03 | 1987-10-29 | Esters of hexahydro-8-hydroxy-2,6-methano-2h-quino-lizin-3(4h)-one and related compounds,processes for their preparation and pharmaceutical compositions containing them |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0266730B1 (de) |
JP (2) | JP2542225B2 (de) |
KR (1) | KR950011737B1 (de) |
CN (1) | CN1021654C (de) |
AR (1) | AR246264A1 (de) |
AT (1) | ATE109779T1 (de) |
AU (1) | AU600318B2 (de) |
CA (1) | CA1329203C (de) |
DE (2) | DE3750359T2 (de) |
DK (1) | DK171116B1 (de) |
ES (1) | ES2061469T3 (de) |
FI (1) | FI87786C (de) |
HU (1) | HU197008B (de) |
IE (1) | IE63670B1 (de) |
IL (1) | IL84309A (de) |
NL (1) | NL970043I2 (de) |
NO (2) | NO165922C (de) |
NZ (1) | NZ222349A (de) |
PH (2) | PH24664A (de) |
PT (1) | PT86060B (de) |
ZA (1) | ZA878096B (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0329902A1 (de) * | 1988-02-23 | 1989-08-30 | Merrell Dow Pharmaceuticals Inc. | Verwendung von Chinolizinon- und Chinolizin-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Psychose |
US5011846A (en) * | 1988-02-23 | 1991-04-30 | Merrell Dow Pharmaceuticals Inc. | Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof |
EP0329904A1 (de) * | 1988-02-23 | 1989-08-30 | Merrell Dow Pharmaceuticals Inc. | Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Anxietas |
EP0329905A1 (de) * | 1988-02-23 | 1989-08-30 | Merrell Dow Pharmaceuticals Inc. | Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Erhöhung der Magenbeweglichkeit |
EP0329903A1 (de) * | 1988-02-23 | 1989-08-30 | Merrell Dow Pharmaceuticals Inc. | Verwendung von Chinolizinon- und Chinolizin-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Glaukom |
DE68924545T2 (de) * | 1988-02-23 | 1996-03-21 | Merrell Dow Pharma | Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln. |
EP0330788A1 (de) * | 1988-03-01 | 1989-09-06 | Merrell Dow Pharmaceuticals Inc. | Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln zur Behandlung von Herz-Arrhythmie |
ZA893008B (en) * | 1988-04-29 | 1989-12-27 | Merrell Dow Pharma | Process for preparing indole-3-carboxylic acid esters of transhexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one |
GB8928837D0 (en) * | 1989-12-21 | 1990-02-28 | Beecham Group Plc | Pharmaceuticals |
EP0492020A1 (de) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Verwendung von bestimmten Estern von Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-on und verwandter Verbindungen zur Behandlung von kognitiven Erkrankungen |
ATE425955T1 (de) * | 1997-12-17 | 2009-04-15 | Biocryst Pharm Inc | Substituierte cyclopentan- und cyclopenten- verbindungen als neuraminidase-blocker |
CN100390172C (zh) * | 2004-09-10 | 2008-05-28 | 成都欣捷高新技术开发有限公司 | 一种甲磺酸多拉司琼晶型及其制备方法 |
EP1819705A1 (de) * | 2004-11-25 | 2007-08-22 | Cilag Ltd. | Verfahren zur herstellung von estern von hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-on |
ES2264901B1 (es) | 2005-07-06 | 2007-12-01 | Inke, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimiento para la obtencion de los mismos. |
DE602006003227D1 (de) * | 2005-07-06 | 2008-11-27 | Inke Sa | Verfahren zur gewinnung der pharmazeutisch aktivendavon und verfahren zu deren gewinnung |
US20070203175A1 (en) * | 2006-01-05 | 2007-08-30 | Janos Hajko | Productioin of dolasetron |
ES2389261T3 (es) | 2007-11-13 | 2012-10-24 | Inke, S.A. | Compuestos intermedios útiles para preparar dolasetrón |
EP2253316B1 (de) | 2009-05-20 | 2013-08-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin-5-HT3-Rezeptorantagonisten zur Verwendung bei der Behandlung oder Prävention einer Innenohr-Pathologie mit Vestibularisdefiziten |
CN102458400B (zh) | 2009-05-20 | 2014-10-08 | 国立健康与医学研究所 | 用于治疗病灶性前庭功能障碍的血清素5-ht3受体拮抗剂 |
EP4019018A1 (de) | 2015-09-11 | 2022-06-29 | Chase Pharmaceuticals Corporation | Muscarinkombination und deren verwendung zur bekämpfung von hypocholinergen störungen des zentralen nervensystems |
CN108976230A (zh) * | 2018-06-18 | 2018-12-11 | 东莞市联洲知识产权运营管理有限公司 | 一种基于石墨烯活化制备甲磺酸多拉司琼关键中间体的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
CH664567A5 (de) * | 1983-08-26 | 1988-03-15 | Sandoz Ag | Aromatische carbonsaeure- und sulfonsaeureester oder -amide. |
CY1908A (en) * | 1984-12-20 | 1985-12-13 | Sandoz Ag | Treatment of gastrointestinal disorders using 5-HT3 antagonists |
-
1987
- 1987-10-28 ZA ZA878096A patent/ZA878096B/xx unknown
- 1987-10-29 FI FI874768A patent/FI87786C/fi not_active IP Right Cessation
- 1987-10-29 IL IL84309A patent/IL84309A/xx not_active IP Right Cessation
- 1987-10-29 CA CA000550612A patent/CA1329203C/en not_active Expired - Lifetime
- 1987-10-29 NZ NZ222349A patent/NZ222349A/xx unknown
- 1987-10-30 PH PH36006A patent/PH24664A/en unknown
- 1987-10-30 AR AR87309166A patent/AR246264A1/es active
- 1987-11-02 NO NO874550A patent/NO165922C/no not_active IP Right Cessation
- 1987-11-02 EP EP87116119A patent/EP0266730B1/de not_active Expired - Lifetime
- 1987-11-02 DE DE3750359T patent/DE3750359T2/de not_active Expired - Lifetime
- 1987-11-02 JP JP62275894A patent/JP2542225B2/ja not_active Expired - Lifetime
- 1987-11-02 AT AT87116119T patent/ATE109779T1/de not_active IP Right Cessation
- 1987-11-02 AU AU80596/87A patent/AU600318B2/en not_active Expired
- 1987-11-02 IE IE295587A patent/IE63670B1/en not_active IP Right Cessation
- 1987-11-02 ES ES87116119T patent/ES2061469T3/es not_active Expired - Lifetime
- 1987-11-02 CN CN87107629A patent/CN1021654C/zh not_active Expired - Lifetime
- 1987-11-02 DE DE1997175092 patent/DE19775092I2/de active Active
- 1987-11-02 DK DK572887A patent/DK171116B1/da not_active IP Right Cessation
- 1987-11-02 HU HU874918A patent/HU197008B/hu unknown
- 1987-11-02 PT PT86060A patent/PT86060B/pt unknown
- 1987-11-03 KR KR1019870012286A patent/KR950011737B1/ko not_active IP Right Cessation
-
1990
- 1990-01-02 PH PH39830A patent/PH26261A/en unknown
-
1996
- 1996-02-27 JP JP8065408A patent/JP2657267B2/ja not_active Expired - Lifetime
-
1997
- 1997-12-17 NL NL970043C patent/NL970043I2/nl unknown
-
1999
- 1999-08-26 NO NO1999020C patent/NO1999020I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT84936A (en) | Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same | |
IL84309A (en) | Esters of hexahydro-8-hydroxy-2,6-methano-2h-quino-lizin-3(4h)-one and related compounds,processes for their preparation and pharmaceutical compositions containing them | |
PT85521A (en) | Process for the preparation of pharmaceutical compositions com-prising microcapsules | |
PT85329A (en) | Process for the preparation of tetrahydronaphtaline and indane derivatives and of pharmaceutical compositions containing the same | |
PT86366A (en) | Process for the preparation of phosphinic acid derivatives and of pharmaceutical compositions containing the same | |
PT86236A (en) | Process for the preparation of catechol derivatives and of pharmaceutical compositions containing them | |
PT84860A (en) | Process for the preparation of novel tetrahydronaphtalene derivatives and of pharmaceutical compositions containing the same | |
IL80411A (en) | Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them | |
PT81015A (en) | Process for the preparation of bicyclic compounds and of pharmaceutical compositions containing | |
PT85762A (en) | Process for the preparation of new cephem compounds and pharmaceutical compositions containing same | |
HU902693D0 (en) | Process for the preparation of n-heteroaryl-4-quinolin-amine compounds and pharmaceutical compositions containing them | |
HU895335D0 (en) | Process for the preparation of spiro-isoquinoline-pyrrolidine-tetrones and analogs thereof and pharmaceutical compositions containing said compounds | |
PT86365A (en) | Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same | |
PT86419A (en) | Process for the preparation of novel chroman derivatives and of pharmaceutical compositions containing the same | |
PT86516A (en) | Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same | |
PT84358A (en) | Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same | |
PT82984A (en) | Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same | |
PT86407A (en) | Process for the preparation of new alkanesulfonanilide derivatives and pharmaceutical compositions comprising the same | |
PT83604A (en) | Process for the preparation of flavone derivatives and of pharmaceutical compositions containing the same | |
NZ222116A (en) | 3-propenylcephem derivatives and pharmaceutical compositions; processes for preparation | |
PT85337A (en) | Process for the preparation of cycloalkyl-substituted 4-pyridil derivatives and of pharmaceutical compositions containing the same | |
PT82395A (en) | Process for the preparation of synthetic derivatives of pseudopterosin and of pharmaceutical compositions containing the same | |
PT85513A (en) | Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same | |
PT85522A (en) | Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same | |
PT86349A (en) | Process for the preparation of triazine derivatives and of pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
HC | Change of name of proprietor(s) |
Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC. |
|
EXP | Patent expired |